STOCK TITAN

OKYO Pharma: Opaleye reports 9.53% passive stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

OKYO Pharma Ltd (OKYO) is the issuer in a Schedule 13G reporting 5,000,000 ordinary shares held directly by Opaleye, L.P. Opaleye Management Inc., the fund’s investment adviser, and James Silverman, the adviser’s controlling person, may each be deemed beneficial owners of the same shares; each reports shared voting and dispositive power and a 9.53% stake. The reported percentage is based on 52,479,527 shares outstanding as of July 15, 2026.

Ordinary shares beneficially owned 5,000,000 shares Reported for each of the three reporting persons; Opaleye, L.P. directly holds the shares.
Percent of class 9.53% Reported by each reporting person.
Ordinary shares outstanding 52,479,527 shares As of July 15, 2026; basis for the reported percentage of class.
beneficially own regulatory
"may be deemed to beneficially own such Ordinary Shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
shared voting power regulatory
"Shared Voting Power 5,000,000.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 5,000,000.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OKYO ordinary shares are reported?

Opaleye, L.P. directly holds 5,000,000 ordinary shares of OKYO Pharma Ltd. The three reporting persons each report shared voting and dispositive power over that same block and beneficial ownership of 9.53% of the class.

Who receives dividends from the reported OKYO shares?

Opaleye, L.P. has the right to receive dividends and sale proceeds from the reported securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





G6724L116

(CUSIP Number)
11/16/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Opaleye Management Inc.
Signature:/s/ James Silverman
Name/Title:President
Date:11/20/2026
Opaleye, L.P.
Signature:Opaleye GP LLC, its general partner /s/ James Silverman
Name/Title:Managing Member
Date:11/20/2026
James Silverman
Signature:/s/ James Silverman
Name/Title:Individually
Date:11/20/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement by and among the reporting persons

Keep reading